703 F.3d 149 (2d Cir. 2012)
The case of U.S. v.
The primary legal question is whether the government's restriction and prosecution of off-label drug promotion under the FDCA violate the First Amendment's protections on free speech.
Commercial speech, while affording lesser protection under the First Amendment than other forms of speech, is nonetheless protected. The principle established by the Central Hudson test determines that any regulation of commercial speech must directly advance a substantial government interest and not be more extensive than necessary.
The court held that the government's application of the FDCA to convict Caronia for his speech promoting lawful, off-label use of an FDA-approved drug violated the First Amendment.
For law students, U.S. v. Caronia is significant because it marks a shift in how courts interpret the balance between government regulation and constitutional freedoms—particularly in commercial contexts. It underscores the evolving nature of First Amendment jurisprudence concerning commercial speech and reflects an essential pivot towards upholding free speech rights in advertising and industry-specific communications. Furthermore, it raises critical discussions on how regulations must be designed to narrowly align with governmental interest without breaching fundamental constitutional protections.